# Dechra Pharmaceuticals (Dechra Pharmaceuticals Limited)

Private limited company registered in Northwich, classed under “Activities of head offices”.

- Company number: 03369634
- Status: Active
- Type: Private limited company
- Incorporated: 13 May 1997
- Registered office: 24 Cheshire Avenue Cheshire Business Park, Lostock Gralam, Northwich, CW9 7UA
- Location: Northwich
- Activity: Activities of head offices
- Website: dechra.com

## Latest filed profit

Profit after tax in the year to 30 June 2023: **loss of £27.9m**, from its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Dechra Pharmaceuticals do?

Private limited company registered in Northwich, classed under “Activities of head offices”.

### How much turnover does Dechra Pharmaceuticals make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/dechra-pharmaceuticals-03369634

### Is Dechra Pharmaceuticals profitable?

No: it made a loss after tax of £27.9m in the year to 30 June 2023, its latest filed accounts.

### Who runs and owns Dechra Pharmaceuticals?

Its directors are Thomas James Bannister, Ajay Gandhi, Jesper Due Nordengaard. Its owners are shown to subscribers.

### Where is Dechra Pharmaceuticals based?

Its registered office is 24 Cheshire Avenue Cheshire Business Park, Lostock Gralam, Northwich, CW9 7UA, in Northwich.

### When was Dechra Pharmaceuticals founded?

Dechra Pharmaceuticals Limited was incorporated on 13 May 1997.

### Is Dechra Pharmaceuticals still trading?

The register lists Dechra Pharmaceuticals Limited as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-07-09: Statement of capital on 9 July 2026 · GBP 22,568,036.23
- 2026-07-09: Statement by Directors (and 2 more like it since 28 January 2019)
- 2026-07-09: Solvency Statement dated 07/07/26
- 2026-07-09: Resolutions (and 7 more like it since 30 October 2019)
- 2026-03-31: Appointment of Mr Thomas James Bannister as a secretary on 31 March 2026
- 2026-03-31: Termination of appointment of Jonathan David Lang as a director on 31 March 2026
- 2026-03-31: Termination of appointment of Melanie Jane Hall as a secretary on 31 March 2026
- 2026-03-09: Audit exemption subsidiary accounts made up to 30 June 2025
- 2026-03-09: Consolidated accounts of parent company for subsidiary company period ending 30/06/25
- 2026-03-09: Notice of agreement to exemption from audit of accounts for period ending 30/06/25
- 2026-03-04: Change of details for Dechra Pharmaceuticals Holdings Limited as a person with significant control on 15 February 2024
- 2025-04-10: Termination of appointment of Paul Nicholas Sandland as a director on 31 March 2025
- 2025-03-05: Appointment of Mr Ajay Gandhi as a director on 5 March 2025
- 2025-03-03: Full accounts made up to 30 June 2024
- 2025-01-31: Registration of charge 033696340014, created on 22 January 2025
- 2025-01-28: Satisfaction of charge 033696340013 in full
- 2025-01-28: Satisfaction of charge 033696340012 in full
- 2024-09-10: Statement of capital following an allotment of shares on 30 August 2024 · GBP 22,568,036.23 (and 29 more like it since 14 March 2019)
- 2024-07-29: Change of details for Freya Bidco Limited as a person with significant control on 8 March 2024
- 2024-07-03: Appointment of Mr Jesper Due Nordengaard as a director on 26 June 2024
- 2024-06-10: Termination of appointment of Ian David Page as a director on 10 June 2024
- 2024-06-10: Appointment of Mr Jonathan David Lang as a director on 10 June 2024
- 2024-05-08: Registration of charge 033696340013, created on 29 April 2024
- 2024-05-08: Registration of charge 033696340012, created on 29 April 2024
- 2024-02-28: Notification of Freya Bidco Limited as a person with significant control on 15 February 2024

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/dechra-pharmaceuticals-03369634